Yang H. Liu
Expertise in
154
conditions

Dr. Yang H. Liu

Emergency Medicine | General Surgery
Rockford Emergency Physicians, LLC
1401 E State St, 
Rockford, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
154
conditions
Rockford Emergency Physicians, LLC
1401 E State St, 
Rockford, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yang Liu is an Emergency Medicine specialist and a General Surgeon in Rockford, Illinois. Dr. Liu is highly rated in 154 conditions, according to our data. His top areas of expertise are Liver Cancer, Triple-Negative Breast Cancer, Necrosis, Endoscopy, and Lithotripsy.

His clinical research consists of co-authoring 17055 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Emergency Medicine
General Surgery
Licenses
Emergency Medicine in IL
Hospital Affiliations
Uw Health
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

ROCKFORD EMERGENCY PHYSICIANS, LLC
1401 E State St, Rockford, IL 61104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Decitabine-primed Tandem Targeting CD19 and CD20 Chimeric Antigen Receptor T Cells Treatment in Relapsed and/or Refractory Non-Hodgkin's Lymphoma Patients
Decitabine-primed Tandem Targeting CD19 and CD20 Chimeric Antigen Receptor T Cells Treatment in Relapsed and/or Refractory Non-Hodgkin's Lymphoma Patients
Enrollment Status: Recruiting
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Decitabine, CD19/CD20-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2
A Randomized, Single-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Efficacy of the Pan-immunotherapy in Subjects With Relapsed/Refractory Ovarian Cancer
A Randomized, Single-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Efficacy of the Pan-immunotherapy in Subjects With Relapsed/Refractory Ovarian Cancer
Enrollment Status: Completed
Publish Date: July 15, 2024
Intervention Type: Drug
Study Drugs: Manganese Chloride, Nab-paclitaxel, Platinum chemotherapy, Sintilimab
Study Phase: Phase 2
Anti-PD-1 Antibody SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma:an Open-label Phase II Trial
Anti-PD-1 Antibody SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma:an Open-label Phase II Trial
Enrollment Status: Unknown
Publish Date: April 01, 2019
Intervention Type: Drug
Study Drugs: SHR-1210 Anti-PD-1 Antibody, Decitabine
Study Phase: Phase 2
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
View 7 Less Clinical Trials

16968 Total Publications

Development of Cysteic Acid-Modified FAP Radioligands for Enhanced Renal Clearance: From Preclinical Optimization to First-in-Human Study.
Development of Cysteic Acid-Modified FAP Radioligands for Enhanced Renal Clearance: From Preclinical Optimization to First-in-Human Study.
Journal: Journal of medicinal chemistry
Published: June 18, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Rebecca S. Sippel
General Surgery
Expertise in
17
conditions
Dr. Rebecca S. Sippel
General Surgery

University Of Wisconsin Medical Foundation Inc

600 Highland Ave, 
Madison, WI 
 (58.9 mi)
608-263-6400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rebecca Sippel is a General Surgeon in Madison, Wisconsin. Dr. Sippel is highly rated in 17 conditions, according to our data. Her top areas of expertise are Hyperparathyroidism, Thyroid Cancer, Parathyroid Adenoma, Parathyroidectomy, and Thyroidectomy. Dr. Sippel is currently accepting new patients.

Expertise in
22
conditions
Dr. Sharon M. Weber
General Surgery | Surgical Oncology
Expertise in
22
conditions
Dr. Sharon M. Weber
General Surgery | Surgical Oncology

University Of Wisconsin Medical Foundation Inc

1 S Park St, 
Madison, WI 
 (57.8 mi)
608-287-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sharon Weber is a General Surgeon and a Surgical Oncologist in Madison, Wisconsin. Dr. Weber is highly rated in 22 conditions, according to our data. Her top areas of expertise are Gallbladder Cancer, Pancreatic Cancer, Gallbladder Disease, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Weber is currently accepting new patients.

Expertise in
9
conditions
Dr. Luke M. Funk
General Surgery
Expertise in
9
conditions
Dr. Luke M. Funk
General Surgery

University Of Wisconsin Medical Foundation Inc

2404 Charles St, 
Rockford, IL 
 (1.0 mi)
608-265-7090
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Luke Funk is a General Surgeon in Rockford, Illinois. Dr. Funk is highly rated in 9 conditions, according to our data. His top areas of expertise are Obesity, Hernia, Hiatal Hernia, Gastric Bypass, and Gastrectomy. Dr. Funk is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Liu's expertise for a condition
ConditionClose
View All 10 Elite Conditions
View All 42 Distinguished Conditions
View All 102 Advanced Conditions
View All 123 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile